טבליס 150 מ"ג - Tavlesse 150 mg

× ×ª×× × ×ª×¨××¤×

××¡× ×××¨××××ª

×××¨×©×

××× ×× ×× × ××¡×¤××

×××××¡ 100 ×"× - Tavlesse 100 mg

×§×××¦× ×¤×¨××§××××××ª (ATC4)

B02BX
Other systemic hemostatics

××¨××× ×¤×¢×× (ATC5)

Fostamatinib AS DISODIUM HEXAHYDRATE 150 MG âB02BX09

×¦××¨×ª ××ª×

×¤××× - PER OS

×¦××¨×ª ××× ××

××××××ª ××¦××¤××ª ×¤×××, FILM COATED TABLETS
××× ××¢×ª ××× ×× ××ª×¨ ×× ××¨×¢×× ××© ××××× ××ª ××ª×¨××¤× ×××ª×× ×××× ×× ××××××¥ ××¤× ×©×××¤××¢ ××¢××× ××¦×¨××

××ª××××

TAVALISSE is indicated for the treatment of chronic immune thrombocytopenia (ITP) in adult patients who are refractory to other treatments.

× ×ª×× × ××¡×

×ª××¨×× ××××× ××¡×

01/02/2023

××××××ª ××¡×

×ª×¨××¤× ××××××ª ××¨××©×× ×¢'× ×¨××¤× ××××× ×× ××××× ×××¨×ª

××ª×××× ××¡×

××ª××××	×ª××¨×× ×××××	×ª××× ×§××× ×	Class Effect	××¦× ××××	××¡××¡ ××××××ª

××¡××¨×ª ××××× ××¡×

××ª×¨××¤× ×ª×× ×ª× ××××¤×× ××ª×¨×××××¦××××¤× ×× ××××× ××××¨ ×¢× ITP (immune thrombocytopenic purpura) ××¨×× ××ª ×× ×¢××§×©×ª (Persistent) ××××¨ ×××¦×× ×××¤×× ××©×ª× ×ª×¨××¤××ª ×××©×¤××ª ×-TPOs.

×¢××× ××¨××¤× ×××××¨××ª ××¢×××

×¢××× ××¨××¤× 10.08.2021

××××¨× ××¢××× 19.08.2021

×¢××× ××¦×¨××	Â ×¢××× ××¦×¨×× ×¢××¨××ª 31.08.2021 ×¢××× ××¦×¨×× ×× ××××ª - Patient information leafletâ 31.08.2021 ×¢××× ××¦×¨×× ×¢×¨×××ª - ÙØ´Ø±Ø© ÙÙÙØ³ØªÙÙÙ Ø¨Ø§ÙÙØºØ© Ø§ÙØ¹Ø±Ø¨ÙØ© 31.08.2021

×¢×¨××× ×××××§××¨×¤×××	×¢×¨××× ×§×©××¨×× ×××××§××¨×¤×××
×××××¡ 150 ×"× ×××××¨ ××©×¨× ×××¨××××ª

×××¤××© ××××¨××	××××¨×× ×-PubMed
××××¢ ××¨×©×ª	RxList WebMD Drugs.com
×©× ××¦×¨×	RIGEL PHARMACEUTICALS, INC., USA
×©× ××¢× ××¨××©××	MEDISON PHARMA LTD
×¨××©×××	×ª××¨×× ×××©×: 4/2020. ×¨××©××× ××ª××¨××:
×ª××¨×× ×¢×××× ×××¨××	16/05/2024

השינוי האחרון נעשה בֹ־16 במאי 2024 ב־05:08

טבליס 150 מ"ג - Tavlesse 150 mg

ויקיתרופות